Hematological Diseases Clinical Trial
Official title:
The Effect of Daily Ginger Drinking on Platelet's Function in the Saudi Population
This study aims to examine the effect of ginger beverage consumption on platelets activity
in apparently healthy Saudi adult volunteers.
As for the Saudi population, consumption of powdered ginger dissolved in hot water is a
common practice. Accordingly, in this study, it is tempting to speculate the effect of this
form of ginger consumption, given in separate time points per day, on platelet aggregation
profile by using platelet aggregation analogues. If positive results were obtained, the herb
could provide natural protection against the development of platelet aggregation
complications and could be a potential alternative to aspirin, used for improving blood
circulation and hematological pathophysiologies in diseased individuals.
Status | Completed |
Enrollment | 40 |
Est. completion date | July 2016 |
Est. primary completion date | July 2016 |
Accepts healthy volunteers | Accepts Healthy Volunteers |
Gender | Both |
Age group | 18 Years to 60 Years |
Eligibility |
Inclusion Criteria: - Apparently healthy Saudi volunteers of either sex - Age group = 18-60 years. Exclusion Criteria: - History of organ abnormalities or concomitant illnesses. - Abnormal platelets count or function. - Individuals with bleeding disorder as Von Willebrand Disorder or Hemophilia. - Known allergy to ginger. - Concurrent warfarin ingestion. - History of ingestion of asprin,clopidogrel, nifedipine, non-steroid anti-inflammatory drugs (NSAIDs) or ethanol within the past two week. - Any volunteer ingests ethanol, aspirin, clopidogrel, wine, beer and contraceptive pills during the study duration will be excluded from the study. - pregnant & lactating women. - Individuals on herbal treatment. - Active G.I ulcers/ recently diagnosed G.I ulcers within one month |
Allocation: Randomized, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Screening
Country | Name | City | State |
---|---|---|---|
Saudi Arabia | King Abdulaziz Medical City - National Guard Hospital | Riyadh | Central |
Lead Sponsor | Collaborator |
---|---|
King Abdullah International Medical Research Center |
Saudi Arabia,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | The effect of ginger beverage consumption on platelets activity will be examined in apparently healthy, Saudi adult volunteers. | 1 year | No | |
Secondary | The demographic characteristics of the sample under study will be identified. | 1 year | No | |
Secondary | Any change in platelet morphology before and after ginger consumption will be studied | 1 year | No | |
Secondary | Platelets' count before and after ginger consumption will be compared. | 1 year | No | |
Secondary | Any change in platelets function after ginger consumption via addition of aggregation analogues will be studied. | 1 year | No |
Status | Clinical Trial | Phase | |
---|---|---|---|
Recruiting |
NCT02241031 -
Megakaryocytic Progenitor Cells for Prophylaxis and Treatment of Thrombocytopenia
|
Phase 2/Phase 3 | |
Recruiting |
NCT02240992 -
MSCs With or Without Peripheral Blood Stem Cell for Treatment of Poor Graft Function and Delayed Platelet Engraftment
|
Phase 2/Phase 3 | |
Completed |
NCT02483325 -
Study Evaluating the Efficacy of Allogeneic Transplant Conditioning With Adaptive Dose Busulfan Intravenous (Busilvex®) in Patients at High Risk of Carrying Blood Diseases
|
Phase 2 | |
Recruiting |
NCT05041933 -
Secure Outsourcing of Carfilzomib in the Treatment of Multiple Myeloma to the Hospital at Home Setting
|
||
Completed |
NCT00675038 -
Pilot Study of Non-Invasive Assessment of Hepatic And Myocardial Iron Through T2* Magnet Resonance Imaging (MRI) In Patients With Iron Overload
|
N/A | |
Active, not recruiting |
NCT03745287 -
A Safety and Efficacy Study Evaluating CTX001 in Subjects With Severe Sickle Cell Disease
|
Phase 2/Phase 3 | |
Recruiting |
NCT05505760 -
Testing Content Delivery Models for MomConnect
|
N/A | |
Recruiting |
NCT00884364 -
Exercise During Chemotherapy for Patients With Hematological Malignancies
|
Phase 3 | |
Recruiting |
NCT01160952 -
Long-term Versus Short-term Sequential Therapy (Intravenous Itraconazole Followed by Oral Solution) of Itraconazole as Primary Prophylaxis in Patients Undergoing Allogeneic Stem Cell Transplantation
|
Phase 2 | |
Completed |
NCT00892502 -
Can Treatment With Bismuth Reduce Toxicity to Chemotherapy and Radiotherapy?
|
N/A | |
Active, not recruiting |
NCT00838643 -
Invasive Aspergillosis After Allogeneic Hematopoietic Stem Cell Transplantation (HSCT)
|
N/A | |
Recruiting |
NCT05329649 -
Evaluation of Safety and Efficacy of CTX001 in Pediatric Participants With Severe Sickle Cell Disease (SCD)
|
Phase 3 | |
Not yet recruiting |
NCT06281496 -
AlloCare - Support and Management of Late Effects After Allogeneic Hematopoietic Stem Cell Transplantation
|
N/A | |
Completed |
NCT02661035 -
Allo HSCT Using RIC for Hematological Diseases
|
Phase 2 | |
Enrolling by invitation |
NCT06277479 -
Late Effects and HRQoL in Survivors of Allo-HSCT - a Cross Sectional Study
|
||
Completed |
NCT00956358 -
Study on Systemic and Airway Biomarkers in Haemopoietic Stem Cell Transplantation
|
N/A | |
Completed |
NCT01344681 -
Micafungin Versus Intravenous Itraconazole as Empirical Antifungal Therapy for Febrile Neutropenic Patients With Hematological Diseases
|
Phase 2 | |
Recruiting |
NCT02083718 -
Peripheral Blood Stem Cell Combined With Mesenchymal Stem Cells for Treatment of Poor Graft Function
|
Phase 2 | |
Recruiting |
NCT02083731 -
MSC for Treatment of CMV Infection
|
Phase 2 | |
Recruiting |
NCT01763099 -
Mesenchymal Stem Cells Combined With Cord Blood for Treatment of Graft Failure
|
Phase 2 |